Skip to main content
Skip to footer
Opens in a new tab
Donate
Search Amyloidosis
Search
×
Facts
Act
Us
Research
Webinars
Resources
Events
News
Shop
Facts
Act
Us
Research
Webinars
Resources
Events
News
Shop
AL
AA
Hereditary
Wild-type
Other
7151 N. Main St. Ste. 2 Clarkston, MI 48346
248-922-9610
Category:
Press Release
Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
September 8, 2026
August 12, 2026 NAPLES, Fla., August 12, 2026 — Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to…
